Romiplostim biosimilar(Geropharma)

N/A

Report date: 2024/01/22 18:05:37

Base Information

Drug NameRomiplostim biosimilar(Geropharma)

Drug Alias NameGP-40141

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein

Mechanisms of ActionThrombopoietin receptor agonists

TargetsThrombopoietin receptor

Therapy Area/IndicationsPurpura, Thrombocytopenic, Idiopathic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryRussian Federation

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesGeropharm

China Registration ClassN/A

Active CompaniesGeropharm

Inactive CompaniesN/A

Active IndicationsPurpura, Thrombocytopenic, Idiopathic

Inactive IndicationsN/A

ATC CodeB02BX04